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Abstract
Neuropeptide Y (NPY) is widely expressed in the central nervous system and influences many 
physiological processes. It is located within the rat quantitative trait locus (QTL) for alcohol 
preference on chromosome 4. Alcohol-nonpreferring (NP) rats consume very little alcohol, but 
have significantly higher NPY expression in the brain than alcohol-preferring (P) rats. We 
capitalized on this phenotypic difference by creating an Npy knockout (KO) rat using the inbred 
NP background to evaluate NPY effects on alcohol consumption. Zinc finger nuclease (ZNF) 
technology was applied, resulting in a 26-bp deletion in the Npy gene. RT-PCR, Western blotting 
and immunohistochemistry confirmed the absence of Npy mRNA and protein in KO rats. Alcohol 
consumption was increased in Npy+/− but not Npy−/− rats, while Npy−/− rats displayed 
significantly lower body weight when compared to Npy+/+ rats. In whole brain tissue, expression 
levels of Npy-related and other alcohol-associated genes, Npy1r, Npy2r, Npy5r, Agrp, Mc3r, 
Mc4r, Crh and Crh1r, were significantly greater in Npy−/− rats, whereas Pomc and Crhr2 
expressions were highest in Npy+/− rats. These findings suggest that the NPY-system works in 
close coordination with the melanocortin (MC) and corticotropin-releasing hormone (CRH) 
systems to modulate alcohol intake and body weight.
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1. Introduction
The selectively bred alcohol-preferring (P) and alcohol-nonpreferring (NP) rat lines are one 
of the best characterized rodent models for studying divergent voluntary alcohol drinking 
behavior (Murphy et al., 2002; Bell et al., 2012; McBride et al., 2014). Using inbred alcohol-
preferring (iP) and -nonpreferring (iNP) rats, genetic studies have successfully located 
quantitative trait loci (QTL) for alcohol preference, with the highest logarithm of odds score 
(LOD score 9.2) on chromosome 4 (Chr 4) in the iP × iNP F2 rats (Bice et al., 1998; Carr et 
al., 1998). The development of Chr 4 congenic strains further demonstrated the importance 
of this genomic region for alcohol preference (Carr et al., 2006) as well as body weight 
(Spence et al., 2013). Additionally, a number of candidate genes within this genomic region, 
including neuropep-tide Y (Npy), corticotropin releasing hormone receptor 2 (Crhr2) (Yong 
et al., 2014), and others, are differentially expressed in various brain regions of the 
selectively bred and inbred rat lines of opposing alcohol preferences (Carr et al., 2007; Liang 
et al., 2010; Bell et al., 2012). Recent RNA-sequencing also revealed major genomic 
landscape differences between P and NP rats, finding greater genetic variability than 
previously identified (Zhou et al., 2013b). NPY is widely expressed in the central nervous 
system (CNS) and has been associated with various psychiatric disorders (Widerlov et al., 
1988; Widdowson et al., 1992), including anxiety (Adrian et al., 1983; Heilig et al., 1989; 
Kask et al., 2002; Thorsell, 2008) and alcoholism (Thiele et al., 1998; Badia-Elder et al., 
2001; Gilpin et al., 2005, 2008b; Zhang et al., 2010). NPY is also implicated in other 
physiological functions (Parker, 2013), including food intake (Clark et al., 1984; Jolicoeur et 
al., 1991; Zarjevski et al., 1993), bone density (Teixeira et al., 2009), and neuronal 
excitability (Woldbye et al., 1996).
Increasing evidence implicates NPY as a very important neuro-peptide in the biology of 
addiction. For instance, NPY levels in various brain regions are profoundly affected by 
chronic administration of cocaine (Wahlestedt et al., 1991) and alcohol (Olling et al., 2007). 
In P rats, intracerebroventricular (ICV) administration of NPY suppressed voluntary alcohol 
consumption (Badia-Elder et al., 2001; Thiele and Badia-Elder, 2003; Thorsell et al., 2005a, 
b; Gilpin et al., 2008c) and over-expression of Npy in the amygdala suppressed increased 
alcohol intake of animals after repeated alcohol deprivation (Thorsell et al., 2007). In 
agreement with studies in mice, our findings with P and NP rats indicate that NPY levels are 
inversely related to free-choice alcohol drinking (Thiele et al., 1998; Spence et al., 2005). 
These studies suggest that low NPY expression is a risk factor for high alcohol use; however, 
previous pharmacological experiments may have overlooked the effect of endogenous NPY. 
Thus, the development of an Npy knockout (KO) animal is an important advance for the 
research community.
NPY also functionally interacts with corticotropin releasing hormone (CRH) (Kash and 
Winder, 2006; Sajdyk et al., 2006) and decreases γ-aminobutyric acid (GABA)-ergic 
signaling in the central amygdala and bed nucleus of the stria terminalis (BNST) (Kash and 
Winder, 2006; Gilpin et al., 2011; Roberto et al., 2012). Additionally, NPY modulates 
catecholaminergic (Fuzesi et al., 2007), dopaminergic (Romano et al., 2014), glutamatergic 
(Patrylo et al., 1999; Smialowska et al., 2002), and serotonergic neuronal activities 
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(Yoshimura et al., 2014) within the mesocorticolimbic and extended amygdala reward 
circuits. Together, these studies indicate that Npy is a critical gene for various 
neurobiological functions including addiction.
Npy KO mice, surprisingly, did not show overt differences in feeding and body weight 
regulation, but they did show increased anxiety in elevated plus maze (EPM) (Palmiter et al., 
1998), open field, and acoustic startle response tests (Bannon et al., 2000). They also showed 
increased susceptibility to seizures (Palmiter et al., 1998) and greater voluntary ethanol 
drinking, as well as resistance to ethanol-induced sedation (Thiele et al., 1998), though the 
magnitude of these differences depended, in part, on the genetic background of the KO mice 
(Thiele et al., 2000). In other words, some of the observed increases in alcohol consumption 
could be attributed to the predisposition of certain strains of mice to prefer alcohol. Our 
study addresses the confounding effect of high alcohol preference by establishing Npy KO 
rats on an iNP background, as they possess a higher level of NPY expression and voluntarily 
consume less ethanol. Thus, any increase in alcohol consumption resulting from Npy 
elimination cannot be attributed to a predisposition to high alcohol consumption.
In this study, we successfully created Npy KO rats using zinc finger nuclease (ZFN) 
technology (Geurts et al., 2009), confirmed by sequencing and expression quantification. 
KO rats were tested for alcohol consumption, body weight, and food intake. Anxiety level 
was assessed with EPM. In addition, specific gene expression levels in the whole brain were 
measured to broaden our understanding of how genes that interact with Npy to control 
alcohol consumption and body weight are affected by the absence of Npy. Based on 
previous research, the most relevant genes include Npy receptors, corticotropin-releasing 
hormone (Crh) and its receptors, agouti-related peptide (Agrp), pro-opiomelanocortin 
(Pomc) and melanocortin (MC) receptors, and brain-derived neurotrophic factor (Bdnf). To 
our knowledge, this is the first Npy KO rat model that has been created, and the KO model 
will be a very useful in vivo tool for research on Npy-related conditions, including anxiety-
like behavior, alcohol and drug addiction, eating and feeding behaviors, and others.
2. Results
2.1. Creation of Npy KO rat
To test the efficiency of the 16 designed ZFN constructs targeting the rat Npy gene (Table 
S1), constructs were transfected into rat C6 cells. Surveyor nuclease analysis showed that 
design #6 had the highest ZFN activity and therefore was used for the single-cell embryo 
injection (Fig. 1A). After multiple attempts, a ZFN-induced KO rat (#65) was successfully 
created. NPY KO was confirmed by Surveyor assay (Fig. 1B). The sequenced result 
indicated a ZFN-induced 26-bp deletion at the targeted site, including 6 bp in intron 1 and 
20 bp in exon 2 (Fig. 1C). The sequencing alignment depicts the difference in the Npy gene 
deletion region between the WT and KO (Fig. 1D). Genotyping was performed on each 
newborn animal (Fig. 1E). The successful creation of Npy KO rats was also confirmed by 
demonstrating only residual expression of Npy mRNA and no expression of neuropeptide 
protein in multiple tissues (Fig. 1F–H). A predicted reading frame shift happened due to the 
20 bp deletion in exon 2, which resulted in earlier termination of NPY protein translation. In 
order to further confirm the null expression of NPY in the KO rats, immunohistochemical 
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staining (IHC) was performed using whole brain sections. Compared to WT (Npy+/+), no 
expression of NPY in the hippo-campus of KO (Npy−/−) was evident in IHC (Fig. 1I). 
Reduced NPY expression was observed in heterozygous (Npy+/−) animals. Therefore, this 
ZFN targeted Npy KO allele was confirmed to be an Npy null allele.
2.2. Npy−/− rats show decreased body weight when compared to WT rats
Both Npy-deficient male and female rats were fertile. Body weight and food intake were 
measured each week for five weeks starting from seven weeks of age in naive animals. We 
observed lower body weight in male Npy−/− when compared to both Npy+/− and Npy+/+ rats 
(Fig. 2A), with the mean body weights at five weeks of age for each genotype depicted in 
Fig. 2B. In females, Npy−/− rats also displayed lower body weight when compared to Npy+/+ 
rats, but no difference was found between Npy−/− and Npy+/− rats (Fig. 2C), with mean body 
weight depicted in Fig. 2D. No significant differences in food intake between the genotypes 
of male rats were observed, while the only difference observed in females was at week 2, 
with significantly less food being consumed by Npy−/− when compared to the other two 
genotypes (Fig. S1).
2.3. Npy+/− rats have higher alcohol consumption than WT rats
Previous studies indicated that the iNP rats have higher Npy expression and lower alcohol 
consumption (Ehlers et al., 1998; Spence et al., 2005). Therefore, in order to identify 
whether Npy gene deletion would affect iNP rat alcohol consumption, voluntary alcohol 
consumption was measured using intermittent (12 h/day, 3 days/week) access to 5% and 
10% EtOH (concurrently available) and water. The intermittent access protocol has been 
shown to increase ethanol consumption in different rat lines (Bell et al., 2014). Interestingly, 
significantly higher alcohol consumption was only observed in Npy+/− rats at 7–10 weeks 
compared to Npy−/− or WT rats. This test was initiated during early adolescence postnatal 
day (PND) 30–35 (i.e., 5 week old rats) (Fig. 3A). Alcohol preference significantly 
increased in 6-, 7-, and 10-week-old Npy+/− rats (P < 0.05), with trends of increases at 8 and 
9 weeks as well (Fig. 3B). During alcohol testing session, body weights were significantly 
lower in 6-, 7-, and 8-week-old male and female Npy−/− rats when compared to Npy+/− and 
WT littermates (Fig. 3C and D). Voluntary alcohol consumption in adulthood also showed 
the same trend, with Npy+/− rats drinking more alcohol than the other two genotypes (Fig. 
S2).
2.4. Npy−/− rats show no alteration in anxiety-like behavior
ICV infusion of NPY can abolish the normal preference for the closed arm in the EPM test 
(Heilig et al., 1989), can reduce the level of punishment response in the Geller-
Seifterpunished responding test (Heilig et al., 1993), and can inhibit or attenuate the fear-
potentiated startle response (Broqua et al., 1995). These studies demonstrate Npy has a dose-
dependent anxiolytic effect. We applied the EPM test, which involves exploration of a plus-
shaped maze consisting of two open and two closed arms, where decreased time in the open 
arms is considered an indicator of elevated anxiety. When compared to Npy−/− and WT rats, 
Npy+/− rats spent a longer time in the open arms (Fig. S3A). However, no statistically 
significant difference was observed in either duration or percentage of time spent in the open 
arm when compared to total time of arm entries (Fig. S3A and C). Likewise, there was no 
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observed significant difference in open arm entries and percentage of open arm entries to 
total arm entries (Fig. S3B and D). Taken as a whole, the results indicate no difference in 
anxiety-like behavior between genotypes.
2.5. Npy elimination affects multiple neuropeptide systems
Genes known to interact with Npy (Npy1r, Npy2r, Npy5r, Crh, Crhr1, Crhr2, Pomc, Mc3r, 
Mc4r, Agrp, and Bdnf) were selected for gene expression measurement. Alcohol use 
disorder is a complex disease involving multiple neuropeptide systems (Bell et al., 2012; 
Roberto et al., 2012; Pleil et al., 2015). Evidence has shown that NPY and its associated Y1, 
Y2, and Y5 receptors (Heilig and Thorsell, 2002; Schroeder et al., 2003; Lin et al., 2004; 
Leising et al., 2009), as well as CRH and its receptors CRH-R1 and CRH-R2 (Ehlers et al., 
1992; Gilpin et al., 2008a; Lowery et al., 2010), influence voluntary alcohol consumption 
and stress responses (Sajdyk et al., 2006). Gene expression analyses revealed that Npy−/− 
and Npy+/− rats have increased Npy1r, Npy2r, and Npy5r expressions in the whole brain 
relative to WT rats (Fig. 4A–C), indicating that the dose effect of knocking out Npy results 
in an increase in these three receptor transcripts, possibly as a means of compensation. 
Similarly, expression levels of Crh, Crhr1, and Crhr2 in the whole brain (Fig. 4D–F) were 
increased in both Npy−/− and Npy+/− rats. Interestingly, Crhr2 expression was the highest in 
Npy+/− rats (Fig. 4F). Studies on alcohol and drug addiction have discovered a clear role for 
MC neuropeptide system (Alvaro et al., 1997; Lindblom et al., 2002; Olney et al., 2014). 
Activation of neurons characterized by their expression of agouti-related peptide (AgRP), an 
antagonist of MC receptors (primarily MC3R and MC4R in the CNS), stimulates 
hypothalamic control of feeding behavior (Aponte et al., 2011). Expression levels of Agrp 
and Mc3r were significantly greater in both Npy+/− and Npy−/− rats while Mc4r was only 
increased in Npy−/− rats (Fig. 5A–C). Evidence obtained in humans and rodents indicates 
that β-endorphin (encoded by the Pomc gene) is critical in the regulation of alcohol drinking 
behavior (Topel, 1988; Racz et al., 2008). The expression of Pomc was higher in the Npy+/− 
rats, but lower in the Npy−/− rats relative to WT controls (Fig. 5D). BDNF modulates 
hippocampal plasticity and hippocampal-dependent memory (Egan et al., 2003), 
dopaminergic reward processing (Pecina et al., 2014), as well as cocaine and alcohol 
responses (Horger et al., 1999; Lu et al., 2004; Jeanblanc et al., 2009). Multiple studies have 
demonstrated that BDNF induces Npy expression (Scharfman and MacLusky, 2008; 
Yoshimura et al., 2009), and likewise, NPY administration up-regulates Bdnf expression 
(Corvino et al., 2012; Croce et al., 2013). In agreement with those findings, the expression 
of Bdnf was observed to be significantly lower in both Npy−/− and Npy+/− rats compared to 
WT controls (Fig. 5E).
3. Discussion
In this study, we successfully created Npy KO rats on an iNP background using ZFN 
technology. Body weight was decreased with no significant change in food intake in Npy−/− 
rats. Alcohol consumption was increased in the Npy+/− rats when tested during both 
adolescence and adulthood. The gene expressions of Npy receptors and Crh and its receptors 
were increased in Npy−/− and Npy+/− rats relative to WT controls. Significant increases in 
expression were also observed for Agrp, Mc3r, and Mc4r in the Npy−/− rats. Pomc and 
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Crhr2 were expressed highest in the Npy+/− rat compared to Npy−/− and WT controls. 
Additionally, Bdnf expression was decreased in the Npy+/− and Npy−/− rats, relative to WT 
controls.
Previous studies have shown that NP rats have lower alcohol intake as well as higher Npy 
gene expression when compared to P rats. Therefore, we hypothesized that higher ethanol 
consumption would be observed in Npy−/− KO rats. Surprisingly, we observed increased 
alcohol consumption only in the Npy+/− rats. Similar result was found in β-endorphin 
knockout study, in which only heterozygous mice displayed increased alcohol consumption 
because of β-endorphin dose effect (Grisel et al., 1999). Our results indicate that Npy indeed 
plays an important role in alcohol consumption, and its endogenous function seems to be 
dose-dependent. In order to understand this phenotype, several other alcohol drinking 
behavior related genes and addiction-relevant neuropeptides were analyzed in the Npy+/+, 
Npy+/−, and Npy−/− rats. In the NPY receptor family, Npy1r, Npy2r, and Npy5r have been 
posited to mediate the effect of central NPY on anxiety-like and alcohol-drinking behaviors 
(Sorensen et al., 2004; Wetherill et al., 2008; Morales-Medina et al., 2010; Tasan et al., 
2010; Roseboom et al., 2014). We confirmed that Npy mRNA expression decreased in 
heterozygous rats and almost no expression was detectable in KO rats; however, NPY 
receptor mRNAs increased in heterozygous rats and to almost doubled in KO rats (Fig. 4). 
This indicates that the expressions of these NPY receptors appear to be negatively correlated 
with NPY levels. This supported our intuition that when NPY levels are reduced, there 
would be an up-regulation of receptor levels in an attempt to maintain equilibrium in 
receptor activity. Similarly, expressions of Crh and its receptors (Crhr1 and Crhr2) were up-
regulated following Npy reduction (+/−) and deletion (−/−). These results are consistent with 
previous studies indicating that the central actions of NPY and CRH have opposing 
functions in the regulation of emotional and reward-seeking behaviors (Sajdyk et al., 2004, 
2006; Pleil et al., 2015). However, Crhr2 levels were significantly higher in Npy+/− than both 
Npy−/− and WT control rats. The increases in ethanol consumption run counter to previous 
work, which indicated that activation of Crhr2 decreases binge-like ethanol drinking 
(Lowery et al., 2010; Ryabinin et al., 2012) and that NP rats possess innately higher Crhr2 
expression in the brain (Yong et al., 2014). Studying the homeostatic balance between 
multiple neuropeptide systems will further reveal the systematic adaptations mediating 
alcohol-drinking behavior. On the other hand, higher expression of Pomc in the 
heterozygous animals appears to be consistent with a previous report that Sardinian alcohol-
preferring (sP) rats have higher Pomc expression in specific brain regions (Zhou et al., 
2013a). POMC is a polypeptide hormone precursor. Prior to alcohol consumption, sP rats 
had higher basal hypothalamic Pomc mRNA expression than Sardinian alcohol-
nonpreferring (sNP) rats, and this expression increased following alcohol consumption. 
(Zhou et al., 2013a). Manipulation of the MC receptor using the melanocortin 3/4 receptor 
agonist MTII decreases alcohol intake in chronic ethanol-drinking Alko alcohol-accepting 
(AA) rats (Ploj et al., 2002; Polidori et al., 2006). High expression of Mc3r and Mc4r in 
Npy−/− rats may play a role in their lower alcohol consumption. This Npy KO rat model 
provides an opportunity to study Npy expression level-dependent effects on other 
neuropeptide systems and how these neuropeptide systems interact to control alcohol 
consumption and other behaviors.
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Previous studies have indicated that NPY and BDNF interact to modulate alcohol addiction. 
For example, it was found that lower BDNF expression is associated with higher alcohol 
consumption (Pandey et al., 2005; Yan et al., 2005; Jeanblanc et al., 2009), and in the P rat, 
higher alcohol consumption is consistent with its lower BDNF level (Moonat et al., 2011). 
Other studies have demonstrated a positive association between BDNF and NPY CNS 
expression levels (Scharfman and MacLusky, 2008; Yoshimura et al., 2009; Corvino et al., 
2012; Croce et al., 2013). In the present study, both Npy+/− and Npy−/− rats displayed 
dramatically reduced Bdnf expression levels (Fig. 5E). This suggests that deficits in NPY 
signaling and decreased BDNF appear to be important elements underlying molecular 
processes mediating alcoholism. However, unexpectedly only Npy+/− rats exhibited the 
higher alcohol drinking phenotype, which indicates that low Bdnf alone is insufficient to 
promote alcohol consumption. Importantly, this is the first evidence that the total or partial 
loss of NPY significantly reduces the expression of Bdnf in a KO model.
The relative expressions of Npy, Agrp, and Pomc were also investigated in relation to body 
weight differences in the Npy−/−, Npy+/−, and WT rats. Npy and Agrp are co-localized in the 
hypothalamus and function as orexigenic peptides (Krashes et al., 2011, 2013; Parker, 2013). 
However, some clinical studies have found that hypothalamic expression levels of Agrp and 
Npy are negatively correlated with body weight change, with higher Agrp expression level 
associated with lower body weights (Alkemade et al., 2012). NPY immunoreactivity is 
lower in obese subjects (Goldstone et al., 2002; Alkemade et al., 2012), while AgRP 
immunoreactivity shows either no change (Goldstone et al., 2002) or a U-shaped correlation 
with BMI (Alkemade et al., 2012). These mixed findings, along with the present results, 
indicate that multiple neuropeptide effects must be considered when investigating 
consumptive behaviors or their consequences. We observed that Npy−/− rats with higher 
Agrp and lower Pomc (Fig. 5B and D) expressions have lower body weights. Previous 
studies have shown that activation of AgRP neurons promotes feeding, while stimulation of 
POMC neurons reduces food intake and body weight (Aponte et al., 2011). In the present 
study, Agrp and Pomc expressions appear to counter each other in Npy−/− and Npy+/− 
animals. Maybe Npy dose is sufficient to maintain body weight. Additionally, this result 
implies that altered body weight in the KO rats is independent of food intake or alcohol 
preference. Thus, other possible mechanisms of energy utilization/balance should be 
considered (Parker et al., 2015).
In view of all the above described gene expression changes, we propose an inverted U-
shaped curve model to understand the drinking behavior contributions of Npy and its related 
genes (Fig. 6). At both ends of the inverted U-shaped relationship, the WT and KO animals 
display low alcohol consumption compared to the Npy heterozygous animals. When Npy 
expression is completely abrogated, other gene expression levels begin to play a 
compensatory role to maintain the network balance that determines alcohol drinking 
behavior. In contrast, with the exception of the high expression levels of Pomc and Crhr2, 
Npy+/− animals expressed medium levels of Npy and other genes that were between the WT 
and KO levels. These heterozygous animals notably drank more alcohol than the other two 
genotypes, which indicates an interplay among Npy, Pomc, and Crhr2.
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The NPY system mediates many physiological and behavioral processes and, as such, is a 
key pharmacological target for many psychiatric disorders (Wu et al., 2011). Creation of the 
Npy KO is a step forward in understanding NPY and its related neuropeptide systems. The 
KO model is a novel tool for the translational research field and will be useful as a genetic in 
vivo means for complex disease research.
4. Materials and methods
4.1. Animals
All animals were housed in facilities fully accredited by the Association for Assessment and 
Accreditation of Laboratory Animal Care (AAALAC). The experimental procedures were 
approved by the Indiana University School of Medicine Institutional Animal Care and Use 
Committee and are in accordance with the guidelines of the Guide for the Care and Use of 
Laboratory Animals.
4.2. ZFN design and testing in cell lines
ZFN constructs were co-designed by Sigma-Aldrich (USA) and the authors. In brief, the 
constructs consisted of sequence-generated zinc-finger proteins that specifically bind to 
targeted sequences, and an endonuclease (Fok I) that forms a heterodimer to cleave the 
target gene. The constructs have been described in detail elsewhere (Cathomen and Joung, 
2008; Maeder et al., 2008; Carbery et al., 2010). Sixteen oligos were designed to target the 
genomic region around exon 2 (Table S1), and all of them were tested for their efficiency in 
knocking out gene expression in rat cell lines. Rat C6 cells were transfected with these pre-
designed ZFNs and were harvested one day after transfection. DNA and RNA were isolated 
and Surveyor nuclease cleavage analysis was performed according to the manufacturer's 
protocol (Transgenomic, USA). CEL-I digestions were performed to cut both strands of the 
DNA heteroduplex and samples were run on a 10% PAGE-TBE gel.
4.3. Creation of Npy KO rats
Background iNP rats were developed by selective breeding for low alcohol preference, 
followed by inbreeding for more than 15 generations (Carr et al., 2006). Embryo collection 
and RNA injection were performed as described previously (Geurts et al., 2009). Genomic 
DNA isolated from all F1 rats was used to sequence areas around the ZFN targeted region 
using four primers (Table S2, Npy-ZFN primers). Primers were designed based on the Npy 
genomic sequence accessed from the Ensembl Genome Browser (accession No. 
ENSRNOG00000009768). These primers were utilized to amplify two overlapping DNA 
fragments that encompassed a 2-kb region including the promoter, exon 1, intron 1, and 
exon 2.
4.4. Food intake and body weight measurement
Food intake and body weight measurements were taken in naive adult animals for five weeks 
starting at about PND 50. Both male and female rats with three genotypes: Npy+/+ (8 males 
and 3 females), Npy+/− (5 males and 3 females), and Npy−/− (8 males and 5 females) were 
measured twice per week for body weight and food intake. Differences were compared 
between genotypes independently for males and females.
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4.5. Free-choice alcohol drinking protocol
Adolescent ethanol-naive male and female rats were tested for voluntary alcohol drinking 
following a previously described protocol (Spence et al., 2013). The three groups of rats, 
Npy+/+ (16 males and 11 females), Npy+/− (6 males and 7 females), and Npy−/− (9 males and 
2 females) rats were used. Alcohol consumption and preference were also tested with three 
groups of rats, Npy+/+ (5 males and 6 females), Npy+/− (4 males and 6 females), and 
Npy−/− (2 females).
4.6. EPM test
Animals of adult age were used for the EPM test (Npy+/+, 5 males and 5 females; Npy+/−, 10 
males and 6 females; Npy−/−, 4 males and 5 females). An Accuscan (USA) EPM test 
apparatus was used. Briefly, the apparatus is made of white acrylic plastic with two open 
arms (50 × 10 cm) at right angles to two wall-enclosed and covered arms (50 × 10 × 50 cm). 
The test arena is elevated 90 cm off of the floor. Each rat was released in the center facing an 
open arm, with each test session lasting 5 min. The levels of brightness were approximately 
45 lx and 10 lx, in the open and closed arms respectively.
4.7. Gene expression
Whole brains were extracted, snap frozen in dry ice-bathed isopentane, transferred on dry 
ice, and stored at −80°C until RNA isolation. RNA was isolated using TRIzol (Life 
Technologies, USA) and purified using the RNeasy Mini Kit (Qiagen, USA). Using the ABI 
PRISM 7300 Sequence Detection System (Life Technologies), the relative mRNA 
expression levels were normalized to Gapdh. The used primers are listed in Table S2. Mixed 
model ANOVA were used and statistical significance was set at P < 0.05.
4.8. ELISA and immunohistochemical staining
Npy levels were measured using the EZRMNPY-27K ELISA kit following the 
manufacturer's instructions (Millipore, USA). For immunohistochemical staining, rats were 
anesthetized by 0.6% sodium pentobarbital (0.08 mL/kg), and perfused transcardially with 
PBS (pH 7.4, 4°C) followed by 4% paraformaldehyde (pH 7.4) for 40 min. Coronal sections 
were prepared at 4 μm thickness using a microtome (Leica manual rotary microtome 
RM2235, Germany). Tissue sections were mounted on 3-aminopropyltriethoxysilane 
(APES) coated slices and dried by incubating the slices at 55°C. After the slices were 
deparaffinized and rehydrated, antigen retrieval was performed using a microwave. 
Nonspecific antibody binding was blocked with goat serum working solution (Zhongshan 
Goldenbridge Biotechnology, China). The slices were then incubated overnight at 4°C with 
the mouse anti-NPY primary antibody (2 mg/mL, SAB1404138, Sigma-Aldrich), and 
incubated with Polink-2 plus Polymer HRP Detection System following the manufacturer's 
instructions (Zhongshan Goldenbridge Biotechnology). Finally, slices were visualized with 
DAB chromagen (Zhongshan Golden-bridge Biotechnology). Photomicrographs were 
acquired using a CTR6000 microscope with a DFC450 C camera (Leica, Germany). For 
negative controls, the primary antibody was replaced with PBS.
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4.9. Statistical analysis
ANOVA was used to compare alcohol consumption followed by post-hoc test. Student's t-
test analysis was used for EPM and gene expression change differences between genotypes. 
The P-value indicated the significance of difference between two genotypes. Statistical 
significance was set at P < 0.05.
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Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Successful creation of Npy KO rats. A: In vitro ZFN activity assay. Rat C6 cells were 
transfected and harvested one day after transfection. The pre-designed ZFNs were validated 
by Surveyor nuclease cleavage analysis, in which endonuclease CEL-I is able to cut both 
strands of a DNA heteroduplex. CEL-I digestions were performed and samples were run on 
a 10% PAGE-TBE gel. Design #6 has the highest ZFN activity (14%). The fraction cut ratio 
was calculated based on the relative intensity of the DNA bands (389 bp, 235 bp and 154 bp) 
using ImageJ software. NEG: negative control. B: Animal #65 was a KO rat that was 
confirmed by Surveyor nuclease cleavage assay. G + C lane is positive control of the assay. 
C: Location of the deletion on the Npy gene. D: A 26-bp deletion was confirmed by 
sequencing, which includes 6 bp in intron 1 and 20 bp in exon 2. Multiple KO sequences 
aligned with Npy+/+ (WT). E: PCR analyses of WT (Npy+/+), H (heterozygous, Npy+/−), and 
KO (Npy−/−) genotypes. F: Npy mRNA expression in the tail of rats with different 
genotypes. G: Npy mRNA expression in the brain of rats with different genotypes. H: NPY 
peptide level in the brain. I: Immunohistochemical staining indicated no expression of NPY 
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in the hippocampus of Npy−/− rats and medium level of NPY expression was observed in 
Npy+/− compared to Npy+/+. Scale bar = 100 μm. *, P < 0.05; NS, not significant.
Qiu et al. Page 17
J Genet Genomics. Author manuscript; available in PMC 2016 October 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 2. 
Naive adult animal body weight analysis. In male rats, significant body weight differences 
were observed between Npy+/+ (n = 8), Npy+/− (n = 5), and Npy−/− (n = 8) genotypes at 
multiple time points (A) and also average body weight (mean ± SEM) of all five weeks are 
shown (B). In female rats (Npy+/+, n = 3; Npy+/−, n = 3; Npy−/−, n = 5), no body weight 
difference was found between Npy−/− and Npy+/− rats at any time point, but significant 
decrease of body weight of Npy−/− and Npy+/− was observed at 7, 8, and 9 weeks when 
compared to Npy+/+ rats (C), and average body weight (mean ± SEM) of all five weeks are 
shown (D). *, P < 0.05; **P < 0.01; NS, not significant.
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Fig. 3. 
Alcohol consumption analysis. Both alcohol consumption (A) and alcohol preference (B) 
were significantly increased in heterozygous (Npy+/−, n = 6 m and 7 f) animals when 
compared to homozygous KO (Npy−/−, n = 16 m and 11 f) and WT (Npy+/+, n = 9 m and 2 
f) animals, when tested with intermittent access to 5% EtOH, 10% EtOH, and water. Body 
weight during drinking sessions was plotted in both male (C) and female (D) rats. 
Significant body weight decreases were observed at 6, 7, and 8 weeks old between KO 
(Npy−/−) and WT (Npy+/+) of both male and female rats. No difference between Npy KO 
and heterozygous (Npy+/−) was observed at any time point. *, P < 0.05; **, P < 0.01; ***, P 
< 0.001.
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Fig. 4. 
Npy function-related gene expression in the brain of Npy KO rats. Significant increase of 
Npy1r, Npy2r, Npy5r, Crh, Crhr1, and Crhr2 expressions was observed in the brain of both 
Npy+/− and Npy−/− animals when compared to Npy+/+ rats, with Crhr2 expressed highest in 
the heterozygous animals. *, P < 0.05; NS, not significant.
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Fig. 5. 
Expression analysis of melanocortin receptors (Mc3/4r), their antagonist (Agrp), Pomc and 
Bdnf. Significant increase of Mc3r and Agrp mRNA expressions was shown in the brain of 
both Npy+/− and Npy−/− animals when compared to Npy+/+ rats (A and B). A significant 
increase of Mc4r was observed in KO rats only (C). Pomc was increased in heterozygous 
animals but decreased in KO rats (D). A significant decrease of Bdnf mRNA expression was 
shown in the brain of both Npy+/− and Npy−/− animals when compared to Npy+/+ (E). *, P < 
0.05; NS, not significant.
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Fig. 6. 
Hypothesized inverted U-shaped relationship between gene expression level and alcohol 
drinking behavior. At both ends of the inverted U-shaped relationship, the WT and KO 
animals showed low alcohol consumption. When Npy expression was completely abrogated, 
other gene expression probably began to play a larger role in determining alcohol drinking 
behavior in the KO rats. Combination of moderate expression of some genes, high 
expression of Pomc, and low expression of Bdnf may contribute to high alcohol 
consumption in heterozygous animal. NPY, neuropeptide Y; NPY R, NPY receptor; CRH, 
corticotropin-releasing hormone; CRH R, CRH receptor; AgRP, agouti-related peptide; 
Mc3r/Mc4r, melanocortin receptor 3/4; Pomc, proopiomelanocortin.
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